Cape Investment Advisory’s Bio-Techne TECH Stock Holding History

Cape Investment Advisory’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$59	–	1253
2025 Q1	$59	Hold	1	–	–	﹤0.01%	1117
2024 Q4	$72	Buy	+1	New	+$73	﹤0.01%	1122

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Cape Investment Advisory's TECH Position: Q2 2025 in Review

Cape Investment Advisory sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 1 share — an estimated $59 sold.

Cape Investment Advisory first reported a position in TECH in Q4 2024 and held it in 2 quarters. The position peaked at $72 in Q4 2024. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Cape Investment Advisory reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Cape Investment Advisory sold 1 Bio-Techne share in Q2 2025, an estimated $59.
Cape Investment Advisory first reported a position in Bio-Techne in Q4 2024 and held it in 2 quarters.
Cape Investment Advisory's Bio-Techne position peaked at $72 in Q4 2024.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Cape Investment Advisory's 13F filing for Q2 2025, filed 19 Aug 2025.